<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We retrospectively investigated the incidence of infusion reactions following cetuximab chemotherapy in 93 patients with <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Patients received chemotherapy treatment from September 2008 to February 2010 at Aichi <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">Cancer</z:e> Center Hospital </plain></SENT>
<SENT sid="2" pm="."><plain>The initial cetuximab dose was 400 mg/m(2), followed weekly by an additional 250 mg/m(2), and biweekly by 500 mg/m(2) </plain></SENT>
<SENT sid="3" pm="."><plain>Infusion reactions were observed in 12 patients (13%), with grade 1 reactions in 6 patients and grade 2 reactions in 6 patients </plain></SENT>
<SENT sid="4" pm="."><plain>Eleven of the 12 patients (92%) experienced infusion reactions during the first treatment </plain></SENT>
<SENT sid="5" pm="."><plain>Typical grade 1 adverse events were <z:hpo ids='HP_0001945'>fever</z:hpo> and chills, <z:hpo ids='HP_0002018'>nausea</z:hpo>, <z:hpo ids='HP_0002013'>vomiting</z:hpo> and <z:hpo ids='HP_0000989'>pruritus</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain><z:chebi fb="2" ids="35475">Non-steroidal anti-inflammatory drugs</z:chebi> were given for <z:hpo ids='HP_0001945'>fever</z:hpo> and chills </plain></SENT>
<SENT sid="7" pm="."><plain>Grade 2 adverse events included <z:hpo ids='HP_0002094'>dyspnea</z:hpo> and wheezing, eruption, facial flushing and <z:mp ids='MP_0000947'>convulsions</z:mp> </plain></SENT>
<SENT sid="8" pm="."><plain>Steroids were given for these symptoms </plain></SENT>
<SENT sid="9" pm="."><plain>Infusion reactions were observed in 3 of the 12 patients (25%) &lt;15 min after intravenous injection, 16-60 min after injection in 3 more patients (25%), and 61-120 min after injection in the remaining 6 patients (50%) </plain></SENT>
</text></document>